Page 3 - Managing Directorgv Prasad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Reddy s gets emergency use authorisation for Sputnik V

Dr Reddy s gets emergency use authorisation for Sputnik V
russiaherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from russiaherald.com Daily Mail and Mail on Sunday newspapers.

Russian direct investment fundDrug controller generalNew drugClincial trials rulesManaging directorgv prasadரஷ்ய நேரடி முதலீடு நிதிமருந்து கட்டுப்படுத்தி ஜநரல்புதியது மருந்து

Dr Reddy s Lab gets emergency use authorisation for Sputnik V in India

Dr Reddy s Lab gets emergency use authorisation for Sputnik V in India
siasat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from siasat.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshRussian direct investment fundDrug controller generalNew drugClincial trials rulesManaging directorgv prasadஆந்திரா பிரதேஷ்ரஷ்ய நேரடி முதலீடு நிதிமருந்து கட்டுப்படுத்தி ஜநரல்புதியது மருந்து

Dr Reddy s Sputnik V covid vaccine emergency use authorisation process begins

URL copied Dr Reddy s begins process to obtain emergency use authorisation for Sputnik V Dr Reddy s Laboratories on Friday said it has approached drugs regulator DCGI for emergency use authorisation (EUA) for COVID-19 vaccine Sputnik V. As part of the review process, the drug major will present the safety profile of phase 2 study, and interim data of phase 3 trial, which is expected to be complete by February 21, 2021, Dr Reddy s said in a statement. In September last year, the Hyderabad-based firm partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and for its distribution rights in India.

Andhra pradeshGamaleya national research institute of epidemiologySerum institute of indiaMinistry of health russia onRussian direct investment fundImage sourceDrugs controller generalBharat biotechSerum instituteLaboratories co chairmanManaging directorgv prasadGamaleya national research instituteDr reddys sputnik vCovid vaccine emergency use authorisationSputnik vDr reddy s

Dr Reddy s to seek emergency use authorisation for Russia s Sputnik V in India

Dr Reddy s to seek emergency use authorisation for Russia s Sputnik V in India As part of the review process, Dr Reddy s will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021. BusinessToday.In | February 19, 2021 | Updated 15:48 IST Sputnik V maintained a consistent efficacy at 91.8 per cent even among the group of 2,144 volunteers over 60 years old, Dr Reddy s said. Drug firm Dr Reddy s Laboratories on Friday said it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation (EUA) for Russia s Sputnik V vaccine against COVID-19.

Serum institute covishieldMinistry of health russia onRussian direct investment fundRussia gamaleya national research institute of epidemiologyDrugs controller generalGamaleya national research instituteManaging directorgv prasadSerum instituteBharat biotechSputnik vCovid 19Covid 19 vaccineDr reddy sDr reddys sputnik vDr reddys covid 19 vaccineஅமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யா ஆன்

Russia s Sputnik V gets DCGI nod for phase 3 clinical trials in India

Dr Reddy s Lab issued a statement on Friday evening stating that they have received permission to conduct phase 3 clinical trials of Sputnik V, by the regulatory body DCGI.

Andhra pradeshNew delhiGamaleya national research institute of epidemiologyDr reddy labPhoto creditSafety monitoring boardLaboratories co chairmanManaging directorgv prasadGamaleya national research instituteCorona virusCoronavirus vaccineCoronavirus vaccine newsCoronavirus vaccine updateCoronavirus vaccine latest updateCovid vaccineCovid 19 vaccine